Antimicrobial resistance (AMR)

Bacteria in Petri dishes
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Bacteria #University of Gothenburg

Study identifies previously unknown antibiotic resistance genes

Genes that make bacteria resistant to antibiotics are much more widespread in our environment than was previously realised. A new study, from Chalmers University of Technology and the University of Gothenburg in Sweden, shows that bacteria in almost all environments carry resistance genes. “We… Read More

#News

Antibiotics
#ABPI #Antibiotics #Antimicrobial resistance (AMR) #Investment #UK government

UK government invests £39 million in AMR research

The UK government will invest up to £39 ($48) million in antimicrobial resistance (AMR) research through the Global AMR Innovation Fund (GAMRIF). The funding includes up to £25 ($30.9) million awarded to support the early development of new antibiotics, vaccines, rapid diagnostics and other products to… Read More

#Editor's Choice #News

#Antimicrobial resistance (AMR) #Bacteria #Gedea Biotech #US patent

US-patent for Swedish bacterial vaginosis therapy

The United States Patent and Trademark Office (USPTO) has granted Gedea Biotech’s patent application 16/753,899 directed to gluconic acid derivatives for preventing and/or treating bacterial infections. The patent can be kept in force until 2038. The specific derivative Glucone-delta lactone (GDL) in pHyph is a well-documented… Read More

#News

Petri dish used for bacterial research
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Bacteria #Sepsis #University of Queensland

Australian sepsis study to power new antibiotic discoveries

University of Queensland (UQ) researchers have led a national study on the four main bacteria that cause sepsis, providing new targets for developing antibiotics. Professor Mark Walker and Professor Mark Schembri from UQ’s Institute for Molecular Bioscience, along with Dr Andre Mu from the University of… Read More

#Editor's Choice #News

Bacteria in Petri dishes
#Antibiotics #Antibodies #Antimicrobial resistance (AMR) #Antimicrobials #Cystic fibrosis #Funding #LifeArc

£3m drug discovery programme for cystic fibrosis

UK-based Cystic fibrosis (CF) Syndicate in Antimicrobial Resistance (AMR) has announced a £3 million ($3.6 million) Collaborative Discovery Programme for drug discovery innovators to accelerate the development of new treatments for people with CF. Funded by UK medical research charity LifeArc, the programme will support approximately… Read More

#News

Antimicrobial resistance
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #The Global Antibiotic Research and Development Partnership #University of Liverpool

GARDP and the University of Liverpool join forces against AMR

The Global Antibiotic Research and Development Partnership (GARDP) and the University of Liverpool have confirmed an agreement to collaborate on new projects to address antimicrobial resistance (AMR) for the benefit of public health. Since 2018, GARDP and the University of Liverpool have been working together to… Read More

#Editor's Choice #News

Dr Edo Kon
#Antibiotic resistance #Antimicrobial resistance (AMR) #Bacteria #Immunology / Virology & Vaccines #mRNA #mRNA-based vaccines

mRNA vaccine 100% effective against deadly bacteria

For the first time, researchers have developed an mRNA vaccine that is 100% effective against a type of bacteria that is lethal to humans, paving the way for effective vaccination against antibiotic-resistant bacteria. The study, conducted in an animal model, demonstrated that all treated animals were… Read More

#News #Trending News

Dr Yue Wang and Professor Jianhua Guo
#Antibiotic resistance #Antibiotics #Antidepressants #Antimicrobial resistance (AMR) #Psychiatry

Common antidepressants increase antibiotic resistance

Researchers have found a range of commonly prescribed antidepressants can increase bacteria’s resistance to antibiotic medications. A study led by Professor Jianhua Guo from University of Queensland’s Australian Centre for Water and Environmental Biotechnology focused on prescription drugs used to treat depressive disorders, anxiety disorders, and other psychological… Read More

#News

Professor Stefano Pagliara
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #European Research Council #Funding

$2 million awarded to antibiotic resistance researcher

A major boost of £1.76 million ($2.16 million) will fund research designed to stop antibiotics failing, to help mitigate the rising threat of antibiotic resistance.  Professor Stefano Pagliara, at the University of Exeter, has received the award to advance his work on controlling the processes and biological… Read More

#News

#AI #Antimicrobial resistance (AMR) #Bioscience #Drug development #Europe #Phage therapy #Research

Grant will allow development of phage therapy diagnostic platform 

Vésale Bioscience, a company in the research and development of solutions and treatments using phage therapy for multi-resistant infections, has received €1.8 million in grants from the European Innovation Council (EIC) Accelerator Fund for its PhageDiag project.  The project is a phagogram using artificial intelligence (AI) that… Read More

#News

Scientists in laboratory
#Antibiotics #Antimicrobial resistance (AMR) #Antimicrobials #Collaboration #Cresset Discovery #Partnership #Screening

Virtual screening partners to find new antimicrobial drugs

Cresset Discovery and the University of Exeter have entered a collaboration to discovery novel antimicrobial drugs.  Cresset Discovery will use virtual screening to identify promising new candidates, building on research led by Dr Stefano Pagliara.  Virtual screening enables chemists to explore new chemical space, discover… Read More

#News

Antibiotics
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Antimicrobials

World Antimicrobial Awareness Week: Antibiotics in the news 

For World Antimicrobial Awareness Week (18-24 November), DDW’s Diana Spencer provides an overview of the latest news in antimicrobial resistance and drug discovery.  1. New class of antibiotics for TB A first-in-class investigational antitubercular agent has shown early bactericidal activity with a low, once-daily oral dose after 14 days of… Read More

#Exclusive Content #News #Trending News

Pseudomonas aeruginosa
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Antimicrobials #Gut microbiome

How antibiotic resistant gut bacteria cause lung infections

An Oxford University study has provided the first evidence that antibiotic resistant bacteria can travel from the gut to the lung, increasing the risk of deadly infections.  The findings coincide with World Antimicrobial Awareness Week and shed light on how antimicrobial resistance (AMR) arises and persists.  … Read More

#News #Trending News

#Antibiotics #Antimicrobial resistance (AMR) #Cancer #Cancer research #Cell therapy #Covid-19 #Drug discovery #Oncology

Five key news stories available on DDW Highlights podcast

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This week started with World Diabetes Day on 14 November and concluded… Read More

#News

#Antibiotics #Antimicrobial resistance (AMR) #Cancer #Cancer research #Cell therapy #Covid-19 #Drug discovery #Oncology

This week in drug discovery (14-18 November)

News round-up for 14-18 November by DDW Digital Content Editor Diana Spencer.  This week started with World Diabetes Day on 14 November and concluded with the start of World Antimicrobial Awareness Week, which aims to improve education and understanding of the growing issue of antimicrobial resistance. … Read More

#News

Antibiotics
#Antibiotic resistance #Antimicrobial resistance (AMR) #WHO

Research into antibiotic-resistant pathogens sees increase since 2017

Research into antibiotic-resistant priority pathogens has boomed in the five years since the World Health Organisation (WHO) released a list of 12 families of bacteria that desperately need new antibiotics.  Data from Elseveir’s Scopus database show that since 2017, 227,808 papers have been published on the 12… Read More

#News